# Florian Heitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/florian-heitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,006 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 55 |
| i10-index | 162 |
| Last Known Institution | Helios Dr. Horst Schmidt Kliniken Wiesbaden |
| OpenAlex ID | https://openalex.org/A5021413572 |
| ORCID iD | 0000-0002-2412-0352 |
| Works | 590 |

## Researcher papers

- [Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk](https://scholariq.org/papers/common-genetic-variation-in-cellular-transport-genes-and-epithelial-ovarian/)
- [Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer](https://scholariq.org/papers/multiple-independent-variants-at-the-tert-locus-are-associated-with-telomere/)
- [GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer](https://scholariq.org/papers/gwas-meta-analysis-and-replication-identifies-three-new-susceptibility-loci-for/)
- [Treatment of recurrent ovarian cancer](https://scholariq.org/papers/treatment-of-recurrent-ovarian-cancer/)
- [Identification of six new susceptibility loci for invasive epithelial ovarian cancer](https://scholariq.org/papers/identification-of-six-new-susceptibility-loci-for-invasive-epithelial-ovarian/)
- [Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase](https://scholariq.org/papers/operability-and-chemotherapy-responsiveness-in-advanced-low-grade-serous-ovarian/)
- [ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer](https://scholariq.org/papers/abca-transporter-gene-expression-and-poor-outcome-in-epithelial-ovarian-cancer/)
- [Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases](https://scholariq.org/papers/triple-negative-and-her2-overexpressing-breast-cancers-exhibit-an-elevated-risk/)
- [Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types](https://scholariq.org/papers/genome-wide-meta-analyses-of-breast-ovarian-and-prostate-cancer-association/)
- [Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer](https://scholariq.org/papers/progression-free-survival-and-safety-at-3-5-years-of-follow-up-results-from-the/)
- [Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-newly-diagnosed-advanced-ovarian/)
- [Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)

## Researcher university

- [Helios Dr. Horst Schmidt Kliniken Wiesbaden](https://scholariq.org/institutions/helios-dr-horst-schmidt-kliniken-wiesbaden/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.